What needs a careful discussion?

In weight trials of Zepbound (tirzepatide), about 25% to 29% of treated people felt sick to their stomach, compared with 8% given a dummy shot.

Other common effects included diarrhea, meaning loose stools, vomiting and constipation, meaning trouble passing stools.

Severe stomach effects can cause fluid loss and injury to the kidneys.

The Zepbound label does not recommend it for severe gastroparesis, which means very slow stomach emptying.

Both tirzepatide labels carry the strongest warning used by the Food and Drug Administration (FDA), called a boxed warning.

It concerns thyroid tumors seen in rats.

It is not known whether the medicine produces these tumors in humans.

Medullary thyroid cancer is a rare thyroid cancer; the labels exclude treatment if you or a relative have had it.

They also rule it out for MEN 2, the name of a rare condition passed down in families, or a known serious allergy to the ingredients.

If a relative’s thyroid cancer diagnosis is the only detail you have, say so. Ask your treating professional to verify the diagnosis in medical records and explain the condition passed down in families. You do not need to identify either illness yourself.

The Zepbound label reports serious swelling and irritation of the pancreas, gallbladder problems and severe allergic reactions.

Lasting or severe pain in the belly, which may spread into the back, is a listed sign of that pancreas problem.

Before treatment, ask: “If I get this pain, whom do I call right away, and when do I need an emergency room?” Keep the answer with the medicine so you know how to get help without waiting for the next visit.

With insulin or certain diabetes pills, tirzepatide can raise the chance of low blood sugar.

The labels also describe a concern about stomach contents entering the lungs during anesthesia, the medicines used for surgery.

Ask the surgical team to review your medicine list and explain the plan before a procedure.